Samsung Biologics' spin-off reignites debate over Samsung Group's incomplete governance, with market watchers eyeing broader restructuring amid regulatory risks.
#YonhapInfomax #SamsungBiologics #GovernanceReform #SpinOff #SamsungElectronics #FinancialRegulation #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=66348